Differential cytotoxicity and internalization of graphene family nanomaterials in myocardial cells

Materials Science and Engineering C

Volumn 73, Issue , 2017, Pages 633-642

  Contreras Torres, Flavio F ^a   Rodríguez Galván, Andrés ^b   Guerrero Beltrán, Carlos E ^a   Martínez Lorán, Erick ^c   Vázquez Garza, Eduardo ^a   Ornelas Soto, Nancy ^a   García Rivas, Gerardo ^a,d  

^a SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d HOSPITAL ZAMBRANO HELLION   (Mexico)

Author keywords

Cytotoxicity; Graphene oxide; Myocardial H9c2

Indexed keywords

CELL CULTURE; CYTOTOXICITY; GRAPHENE; GRAPHENE OXIDE; GRAPHITE; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIGHT SCATTERING; MEDICAL APPLICATIONS; NANOSTRUCTURED MATERIALS; OXYGEN; PARTICLE SIZE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SURFACE CHEMISTRY;

BIOMEDICAL APPLICATIONS; BIOMEDICAL DEVICES; FOURIER TRANSFORM INFRA REDS; HIGH-ANGLE ANNULAR DARK FIELDS; MORPHOLOGICAL ALTERATION; MYOCARDIAL H9C2; QUALITATIVE ANALYSIS; TOXICOLOGICAL ASSESSMENT;

CELLS;

GRAPHITE; NANOMATERIAL;

ANIMAL; CARDIAC MUSCLE CELL; CELL DEATH; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; ENDOCYTOSIS; FLOW CYTOMETRY; IC50; INFRARED SPECTROSCOPY; OXIDATION REDUCTION REACTION; RAMAN SPECTROMETRY; RAT; ULTRASTRUCTURE; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; CELL DEATH; CELL LINE; CELL SURVIVAL; ENDOCYTOSIS; FLOW CYTOMETRY; GRAPHITE; INHIBITORY CONCENTRATION 50; MYOCYTES, CARDIAC; NANOSTRUCTURES; OXIDATION-REDUCTION; PHOTOELECTRON SPECTROSCOPY; RATS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN;

EID: 85008240315     PISSN: 09284931     EISSN: 18730191     Source Type: Journal    
DOI: 10.1016/j.msec.2016.12.080     Document Type: Article

References (63)

1. [1] Boisseau, P., Loubation, B., Nanomedicine, nanotechnology in medicine. C. R. Phys. 12 (2011), 620–636.
2. [2] Wang, Y., Li, Z., Wang, J., Li, J., Lin, Y., Graphene and graphene oxide biofunctionalization and applications in biotechnology. Trends Biotechnol. 29 (2011), 205–212.
3. [3] Brodie BC, B.C., On the atomic weight of graphite. Philos. Trans. R. Soc. London, Ser. A 149 (1859), 249–259.
4. [4] Staudenmaier, L., Verfahren zur Darstellung der Graphitsaüre. Ber. Dtsch. Chem. Ges. 31 (1898), 1481–1487.
5. [5] Hummers, W.S., Offeman, R.E., J. Am. Chem. Soc., 80, 1958, 1339.
6. [6] Marcano, D.C., Kosynkin, D.V., Berlin, J.M., Sinitskii, A., Sun, Z., Slesarev, A., Alemany, L.B., Lu, W., Tour, J.M., Improved synthesis of graphene oxide. ACS Nano 4 (2010), 4806–4814.
7. [7] Dimiev, A., Kosynkin, D.V., Alemany, L.B., Chaguine, P., Tour, J.M., Pristine graphite oxide. J. Am. Chem. Soc. 134 (2012), 2815–2822.
8. [8] Lee, J., Min, D.H., A simple fluorometric assay for DNA exonuclease activity based on graphene oxide. Analyst 137 (2012), 2024–2026.
9. [9] Zhang, M., Yin, B.C., Wang, X.F., Ye, B.C., Interaction of peptides with graphene oxide and its application for real-time monitoring of protease activity. Chem. Commun. 47 (2011), 2399–2401.
10. [10] Kim, H., Namgung, R., Singha, K., Oh, I.K., Kim, W.J., Graphene oxide-polyethyleneimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjug. Chem. 22 (2011), 2558–2567.
11. [11] Bao, H.Q., Pan, Y.Z., Ping, Y., Sahoo, N.G., Wu, T., Li, L., Li, J., Gan, L.H., Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7 (2011), 1569–1578.
12. [12] Lee, W.C., Lim, C.H.Y.X., Shi, H., Tang, L.A.L., Wang, Y., Lim, C.T., Loh, K.P., Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. ACS Nano 5 (2011), 7334–7341.
13. [13] Fan, H.L., Wang, L.L., Zhao, K.K., Li, N., Shi, Z., Ge, Z., Jin, Z., Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites. Biomacromolecules 11 (2010), 2345–2351.
14. [14] Surya, S., Nalva, H.S., Nanotechnology and health safety-toxicity and risk assessments of nanostructured materials on human health. J. Nanosci. Nanotechnol. 7 (2007), 3048–3070.
15. [15] Seabra, A.B., Paula, A.J., de Lima, R., Alves, O.L., Durán, N., Nanotoxicity of graphene and graphene oxide. Chem. Res. Toxicol. 27 (2014), 159–168.
16. [16] Liu, X.T., Mu, X.Y., Wu, X.L., Meng, L.X., Guan, W.B., Ma, Y.Q., Sun, H., Wang, C.J., Li, X.F., Toxicity of multi-walled carbon nanotubes, graphite oxide, and reduced graphite oxide to zebrafish embryos. Biomed. Environ. Sci. 27 (2014), 676–683.
17. [17] Nezakati, T., Cousins, B.G., Seifalian, A.M., Toxicology of chemically modified graphene-based materials for medical application. Arch. Toxicol. 88 (2014), 1987–2012.
18. [18] Wang, K., Ruan, J., Song, H., Zhang, J., Wo, Y., Guo, S., Cui, D., Biocompatibility of graphene oxide. Nanoscale Res. Lett. 6 (2011), 1–8.
19. [19] Wang, A., Pu, K., Dong, B., Liu, Y., Zhang, L., Zhang, Z., Duan, W., Zhu, Y., Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J. Appl. Toxicol. 33 (2013), 1156–1164.
20. [20] Chang, Y., Yang, S.T., Liu, J.H., Dong, E., Wang, Y., Cao, A., Liu, Y., Wang, H., In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol. Lett. 200 (2011), 201–210.
21. [21] Lammel, T., Boisseaux, P., Fernández-Cruz, M.-L., Navas, J.M., Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2. Part. Fibre Toxicol., 10, 2013 (Art. No. 27).
22. [22] Wang, Y., Wu, S., Zhao, X., Su, Z., Du, L., Sui, A., In vitro toxicity evaluation of graphene oxide on human RPMI 8226 cells. Biomed. Mater. Eng. 24 (2014), 2007–2013.
23. [23] Liao, K.H., Lin, Y.S., Macosko, C.W., Haynes, C., Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl. Mater. Interfaces 3 (2011), 2607–2615.
24. [24] Guo, X., Mei, N., Assessment of the toxic potential of graphene family nanomaterials. J. Food Drug Anal. 22 (2014), 105–115.
25. [25] Pei, S., Cheng, H.-M., The reduction of graphene oxide. Carbon 50 (2012), 3210–3228.
26. [26] Hu, W., Peng, C., Luo, W., Min, L., Li, X., Li, D., Huang, Q., Fan, C., Graphene-based antibacterial paper. ACS Nano 4 (2010), 4317–4323.
27. [27] Chatterjee, N., Eom, H.J., Choi, J., A systems toxicology approach to the surface funcionality control of graphene-cell interaction. Biomaterials 35 (2014), 1109–1127.
28. [28] Arghya, P., Hasan, A., Al Kindi, H., Gaharwar, A.K., Rao, V.T.S., Nikkhah, M., Shin, S.R., Krafft, D., Dokmeci, M.R., Shum-Tim, D., Khademhosseini, A., Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair. ACS Nano 8 (2014), 8050–8062.
29. [29] Qiao, Y., Zhang, P., Wang, C., Ma, L., Su, M., Reducing X-ray induced oxidative damages in fibroblasts with graphene. Nanomaterials 4 (2014), 522–534.
30. [30] Roberts, J.R., Mercer, R.R., Stefaniak, A.B., Seehra, M.S., Geddam, U.K., Chaudhuri, I.S., Kyrlidis, A., Kodali, V.K., Sager, T., Kenyon, A., Bilgesu, S.A., Eye, T., Scabilloni, J.F., Leonard, S.S., Fix, N.R., Schwegler-Berry, S., Farris, B.Y., Wolfarth, M.G., Porter, D.W., Castranova, V., Erdely, A., Evaluation of pulmonary and systemic toxicity following lung exposure to graphite nanoplates: a member of the graphene-based nanomaterial family. Part. Fibre Toxicol., 13, 2016, 34.
31. [31] Dreyer, D.R., Park, S., Bielawski, W., Ruoff, R.S., The chemistry of graphene oxide. Chem. Soc. Rev. 39 (2010), 228–240.
32. [32] Chng, E.L.K., Pumera, M., The toxicity of graphene oxides: dependence on the oxidative methods used. Chem. Eur. J. 19 (2013), 8227–8235.
33. [33] Akhavan, O., Ghaderi, E., Akhavan, A., Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 33 (2012), 8017–8025.
34. [34] Wu, S.Y., An, S.S.A., Hulme, J., Current applications of graphene oxide in nanomedicine. Int. J. Nanomedicine 10 (2015), 9–24.
35. [35] Pinto, A.M., Goncalves, C., Souza, D.M., Ferreira, A.R., Moreira, J.A., Goncalves, I., Magalhaes, F.D., Smaller particle size and higher oxidation improves biocompativility of graphene-based materials. Carbon 99 (2016), 318–329.
36. [36] Al-Nasiry, S., Guesens, N., Hanssens, M., Luyten, C., Pijnenborg, R., The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum. Reprod. 22 (2007), 1304–1309.
37. [37] Suzuki, H., Toyooka, T., Ibuki, Y., Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis. Environ. Sci. Technol. 41 (2007), 3018–3024.
38. [38] Chua, C.H., Pumera, M., The reduction of graphene oxide with hydrazine: elucidating its reductive capability based on a reaction-model approach. Chem. Commun. 52 (2016), 72–75.
39. [39] Xu, Y., Bai, H., Lu, G., Li, C., Shi, G., Flexible graphene films via the filtration of water-soluble noncovalent functionalized graphene sheets. J. Am. Chem. Soc. 130 (2008), 5856–5857.
40. [40] Davies, M.B., Austin, J., Partridge, D.A., Vitamin C: Its Chemistry and Biochemistry. 1991, Royal Society of Chemistry, Cambridge, U.K.
41. [41] Ferrari, A., Robertson, J., Interpretation of Raman spectra of disordered and amorphous carbon. Phys. Rev. B 61 (2000), 14095–14107.
42. [42] Chua, C.K., Pumera, M., Chemical reduction of graphene oxide: a synthetic chemistry viewpoint. Chem. Soc. Rev. 43 (2014), 291–312.
43. [43] Kaniyoor, A., Ramaprabhu, S., A Raman spectroscopic investigation of graphite oxide derived graphene. AIP Adv., 2, 2012 (art. no. 032183).
44. [44] Tuinstra, F., Koenig, J.L., Raman spectrum of graphite. J. Chem. Phys. 53 (1970), 1126–1130.
45. [45] Stankovich, S., Dikin, D.A., Piner, R.D., Kohlhaas, K.A., Kleinhammes, A., Jia, Y., Wu, Y., Nguyen, S.-B.T., Ruoff, R.S., Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon 45 (2007), 1558–1565.
46. [46] Zhang, J., Yang, H., Shen, G., Cheng, P., Zhang, J., Guo, S., Reduction of graphene oxide via L-ascorbic acid. Chem. Commun. 46 (2010), 1112–1114.
47. [47] Fernández-Merino, M.J., Guardia, L., Paredes, J.I., Villar-Rodil, S., Solís-Fernández, P., Martínez-Alonso, A., Tascón, J.M.D., Vitamin C is an ideal substitute for hydrazine in the reduction of graphene oxide suspensions. J. Phys. Chem. C 114 (2010), 6426–6432.
48. [48] Gonçalves, G., Vila, M., Bdikin I, I., de Andrés, A., Emami, N., Ferreira, R.A.S., Carlos, L.D., Grácio, J., Marques, P.A.A.P., Breakdown into nanoscale of graphene oxide: confined hot spot atomic reduction and fragmentation. Sci. Report., 4, 2014, 6735.
49. [49] Szabó, T., Berkesi, O., Forgó, P., Josepovits, K., Sanakis, Y., Petridis, D., Dékány, I., Evolution of surface functional groups in a series of progressively oxidized graphite oxides. Chem. Mater. 18 (2006), 2740–2749.
50. [50] Gurunathan, S., Han, J.W., Eppakayala, V., Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. Int. J. Nanomedicine 8 (2013), 1015–1027.
51. [51] Lee, T.J., Park, S., Bhang, S.H., Yoon, J.K., Jo, I., Jeong, G.J., Hong, B.H., Kim, B.S., Graphene enhances the cardiomyogenic differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 452 (2014), 174–180.
52. [52] Tuteja, S.K., Priyanka, D., Bhalla, V., Deep, A., Paul, A.K., Suri, C.R., Graphene-gated biochip for the detection of cardiac marker Troponin I. Anal. Chim. Acta 809 (2014), 148–154.
53. [53] Kim, T., Kahng, Y.H., Lee, T., Lee, K., Kim, D.H., Graphene films show stable cell attachment and biocompatibility with electrogenic primary cardiac cells. Mol. Cell 36 (2013), 577–582.
54. [54] Kailashiya, J., Singh, N., Singh, S.K., Agrawai, V., Dash, D., Graphene oxide-based biosensor for detection of platelet-derived microparticles: a potential tool for thrombus risk identification. Biosens. Bioelectron. 65 (2015), 274–280.
55. [55] Brown, D.A., O'Rourke, B., Cardiac mitochondria and arrhythmias. Cardiovasc. Res. 88 (2010), 241–249.
56. [56] Mukhopadhyay, P., Rajesh, M., Yoshihiro, K., Haskó, G., Pacher, P., Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem. Biophys. Res. Commun. 358 (2007), 203–208.
57. [57] Liu, J., Yang, S., Zhang, X., Liu, G., Yue, X., Isoflurane reduces oxygen-glucose deprivation-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes. Am. J. Transl. Res. 8 (2016), 2597–2608.
58. [58] Park, J., Kim, B., Han, J., Oh, J., Park, S., Ryu, S., Jung, S., Shin, J.Y., Lee, B.S., Hong, B.H., Choi, D., Kim, B.S., Graphene oxide flakes as a cellular adhesive: prevention of reactive oxygen species mediated death of implanted cells for cardiac repair. ACS Nano 26 (2015), 4987–4999.
59. [59] Sasidharan, A., Panchakarla, L.S., Chandran, P., Menon, D., Nair, S., Rao, C.N., Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale 3 (2011), 2461–2464.
60. [60] Hu, W., Peng, C., Lv, M., Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5 (2011), 3693–3700.
61. [61] Linares, J., Matesanz, M.C., Vila, M., Feito, M.J., Goncalves, G., Vallet-Regi, M., Marques, P.A., Portoles, M.T., Endocytic mechanisms of graphene oxide nanosheets in osteoblasts, hepatocytes and macrophages. ACS Appl. Mater. Interfaces 6 (2014), 13697–13706.
62. [62] Matesanz, C., Vila, M., Feito, M.J., Linares, J., Gonçalves, G., Vallet-Regí, M., Marques, P.A., Portolés, M.T., The effects of graphene oxide nanosheets localized on F-actin filaments on cell-cycle alterations. Biomaterials 34 (2013), 1562–1569.
63. [63] Chen, Y., Hu, X., Sun, J., Zhou, Q., Specific nanotoxicity of graphene oxide during zebrafish embryogenesis. Nanotoxicology 10 (2016), 42–52.